Dr. Yatin Gokarn
Alexion, Vice President
Yatin is Vice President and Head of Product Development and Clinical Supply, the end-to-end CMC organization for developing Alexion’s multi-modality rare disease portfolio. Yatin has twenty-plus years of bio/pharma experience in building, transforming, and leading high-performing global teams at Sanofi, Gilead, Genentech/Roche, Amgen, and Pfizer. He has direct experience in developing mAbs, multi-specifics, ADCs, fusions, PEG-proteins, nanobodies, peptides, oligonucleotides, synthetics, and the emerging cell and gene therapy modalities. Yatin has contributed to the success of 15+ commercial products through development, licensure, and/or life cycle management. He also has a demonstrated record of sustained scientific excellence with 10+ patent grants (100+ applications) and 25+ high impact publications in journals such as Science Advances (2020), Nature Reviews (2019), and PNAS (2011).